ArticleScientific reports2018
Pharmacological difference between degrader and inhibitor against oncogenic BCR-ABL kinase.
Norihito Shibata et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this papercites it
ArticleScientific reports2018
Norihito Shibata et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.